Abstract:In order to discover and develop the new HIV-1 Centrist, a series of 5-alkyl-6-(benzo[d][1,3]dioxol-5-ylalkyl)-2-mercaptopyrimidin-4(3H)-ones was synthesized and screened for their in vitro cytotoxicity against HIV-1. Most of the compounds we synthetized showed high activity against wild-type HIV-1 strain (IIIB) while IC50 values are in the range of 0.06-12.95μM. Among them, the most active HIV-1 inhibitor was compound 6-(benzo[d][1,3]dioxol-5-ylmethyl)-5-ethyl-2-((2-(4-hydroxyphenyl)-2-oxoethyl)thio)pyrimidin-4(3H)-one (5b), which exhibited similar HIV-1 inhibitory potency (IC50 = 0.06μM, CC50 = 96.23μM) compared with nevirapine (IC50 = 0.04μM, CC50 >200μM) and most of compounds exhibited submicromolar IC50 values indicating they were specific RT inhibitors. The compounds 5b, 6-(benzo[d] [1,3]dioxol-5-yl)-5-ethyl-2-((2-(4-hydroxyphenyl)-2-oxoethyl)thio)pyrimidin-4(3H)-one (5c) and 4-(2-((4-(benzo[d][1,3]dioxol-5-ylmethyl)-5-ethyl-6-oxo-1,6-dihydro pyrimidin-2-yl)thio)acetyl)phenylbenzo[d][1,3]dioxole-5-carboxylate (5r) were selected for further study. It was found that all of them had little toxicity to peripheral blood mononuclear cell (PBMC), and had a good inhibitory effect on the replication of HIV-1 protease inhibitor resistant strains, fusion inhibitor resistant strains and nucleosides reverse transcriptase inhibitor resistant strains, as well as on clinical isolates. Besides, compound 5b and 5c showed inhibition of HIV-1 RT RNA-dependent DNA polymerization activity and DNA-dependent DNA polymerization activity, while compound 5r only showed inhibition of HIV DNA-dependent DNA polymerization activity, which was different from classical reverse transcriptase inhibitors. Our study which offered the preliminary structure-activity relationships and modeling studies of these new compounds has provided the valuable avenues for future molecular optimization.

Anti Human Immunodeficiency Virus-1 (Hiv-1) Agents 1. Discovery of Benzyl Phenyl Ethers As New Hiv-1 Inhibitors in Vitro

Anti Human Immunodeficiency Virus Type 1 (Hiv-1) Agents 4. Discovery Of 5,5 '-(P-Phenylenebisazo)-8-Hydroxyquinoline Sulfonates As New Hiv-1 Inhibitors In Vitro

Synthesis and Biological Evaluation of Benzophenone Derivatives As Potential HIV-1 Inhibitors.

Anti Hiv-1 Agents 2. Discovery of Dibenzofurans As New Hiv-1 Inhibitors in Vitro

Design, Synthesis, and Biological Evaluation of Novel Benzoyl Diarylamine/ether Derivatives as Potential Anti-HIV-1 Agents.

ChemInform Abstract: Anti Human Immunodeficieny Virus‐1 (HIV‐1) Agents. Part 1. Discovery of Benzyl Phenyl Ethers As New HIV‐1 Inhibitors in Vitro.

Synthesis and Anti-Human Immunodeficiency Virus Type 1 Activity of (E)-N-phenylstyryl-n-alkylacetamide Derivatives

Discovery of Novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-n-arylacetamides As Potent Hiv-1 Inhibitors Using A Structure-Based Bioisosterism Approach

Anti Human Immunodeficiency Virus-1 (Hiv-1) Agents 3. Synthesis And In Vitro Anti-Hiv-1 Activity Of Some N-Arylsulfonylindoles

Anti Hiv-1 Agents 7. Discovery of 1-Hydroxy-4-chloro-9,10-anthraquinone Derivatives As New Hiv-1 Inhibitors in Vitro

Anti HIV-1 Agents 6. Synthesis and Anti-Hiv-1 Activity of Indolyl Glyoxamides.

Synthesis and Biological Evaluation of (±)-Benzhydrol Derivatives As Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs

Synthesis and Biological Evaluation of a Series of 2-(((5-akly/aryl-1h-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3h)-ones As Potential HIV-1 Inhibitors.

Design, Synthesis, and Antiviral Evaluation of Novel Hydrazone‐substituted Thiophene[3,2‐d]pyrimidine Derivatives As Potent Human Immunodeficiency Virus‐1 Inhibitors

Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

The Anti-Hiv-1 Activities of Benzophenones Non-Nucleoside Reverse Transcriptase Inhibitors in Vitro

Synthesis of New 2-(N-arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones As Hiv-1 Inhibitors in Vitro

Synthesis and Biological Evaluation of 6‐substituted 5‐alkyl‐2‐(phenylaminocarbonylmethylthio)pyrimidin‐4(3h)‐ones As Potent HIV‐1 NNRTIs

Synthesis of Benzocycloheptene Derivatives As CCR5 Antagonists with Potent Anti-Hiv Activity

Discovery of Novel 1,4-Disubstituted 1,2,3-Triazole Phenylalanine Derivatives As HIV-1 Capsid Inhibitors